IDD001E
Total Payments
$31,057
Transactions
7
Doctors
0
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2020 | $15,473 | 4 | 0 |
| 2019 | $15,584 | 3 | 0 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $31,057 | 7 | 100.0% |
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| PILOT STUDY IN COPD AND ASTHMATIC PATIENTS TO ASCERTAIN PATIENT ACCEPTABILITY/SUITABILITY AND TECHNOLOGICAL FEASIBILITY OF DATA COLLECTION BY REMOTE MONITORING DEVICES | Novartis Pharmaceuticals Corporation | $31,057 | 0 |
Top Doctors Receiving Payments for IDD001E
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Gilbert, AZ | $31,057 | 7 |
Ad
Manufacturing Companies
Product Information
- Type Device
- Total Payments $31,057
- Total Doctors 0
- Transactions 7
About IDD001E
IDD001E is a device associated with $31,057 in payments to 0 healthcare providers, recorded across 7 transactions in the CMS Open Payments database. The primary manufacturer is Novartis Pharmaceuticals Corporation.
Payment data is available from 2019 to 2020. In 2020, $15,473 was paid across 4 transactions to 0 doctors.
The most common payment nature for IDD001E is "Unspecified" ($31,057, 100.0% of total).
IDD001E is associated with 1 research study, including "PILOT STUDY IN COPD AND ASTHMATIC PATIENTS TO ASCERTAIN PATIENT ACCEPTABILITY/SUITABILITY AND TECHNOLOGICAL FEASIBILITY OF DATA COLLECTION BY REMOTE MONITORING DEVICES" ($31,057).